Related Experiment Video
Updated: Mar 18, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis
Dominique Bozec1,2, Alina C Iuga3, Giulia Roda4,5
1Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Abstract:
Necroptosis is a programmed form of non-apoptotic cell death that requires the kinase activity of the receptor interacting protein kinase 3 (RIPK3). Although in vitro data suggests that cancer cells lacking expression of RIPK3 are invasive, the physiological role of RIPK3 in a disease-relevant setting remains unknown. Here we provide evidence that RIPK3 has a critical role in suppressing colorectal cancer (CRC). RIPK3-deficient mice were highly susceptible to colitis-associated CRC and exhibited greater production of pro-inflammatory mediators and tumor promoting factors. Tumorigenesis in RIPK3-deficiency resulted from uncontrolled activation of NF-κB, STAT3, AKT and Wnt-β-catenin signaling pathways that enhanced the ability of intestinal epithelial cells (IECs) to aberrantly proliferate in the face of the sustained inflammatory microenvironment and promote CRC. We found that RIPK3 expression is reduced in tumors from patients with inflammatory bowel diseases, and further confirmed that expression of RIPK3 is downregulated in human CRC and correlated with cancer progression. Thus, our results reveal that the necroptosis adaptor RIPK3 has key anti-inflammatory and anti-tumoral functions in the intestine, and define RIPK3 as a novel colon tumor suppressor.
Insights
Receptor interacting protein kinase 3 (RIPK3) suppresses colorectal cancer (CRC) by controlling inflammation and cell proliferation. Loss of RIPK3 promotes tumor growth, highlighting its role as a colon tumor suppressor.
Area of Science:
- Cell Biology
- Immunology
- Oncology
Background:
- Necroptosis, a programmed cell death, is regulated by receptor interacting protein kinase 3 (RIPK3).
- In vitro studies suggest RIPK3-deficient cancer cells are invasive, but its in vivo role in cancer remains unclear.
Purpose of the Study:
- To investigate the physiological role of RIPK3 in colorectal cancer (CRC) development.
- To determine if RIPK3 functions as a tumor suppressor in the intestine.
Main Methods:
- Utilized RIPK3-deficient mice to study colitis-associated CRC.
- Analyzed inflammatory mediators, tumor-promoting factors, and key signaling pathways (NF-κB, STAT3, AKT, Wnt-β-catenin).
- Examined RIPK3 expression in human inflammatory bowel disease and CRC patient tumors.
Main Results:
- RIPK3-deficient mice showed increased susceptibility to colitis-associated CRC with elevated pro-inflammatory and tumor-promoting factors.
- Tumorigenesis in RIPK3-deficient mice was driven by uncontrolled NF-κB, STAT3, AKT, and Wnt-β-catenin signaling, promoting aberrant intestinal epithelial cell proliferation.
- RIPK3 expression was reduced in human inflammatory bowel disease and CRC tumors, correlating with cancer progression.
Conclusions:
- RIPK3 plays a critical role in suppressing colorectal cancer.
- RIPK3 exhibits anti-inflammatory and anti-tumoral functions in the intestine.
- RIPK3 is identified as a novel colon tumor suppressor, crucial for preventing CRC development.
More Related Videos
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
08:15Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
PI3K/mTOR/AKT Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
The Extrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...